# Cardiovascular Outcomes Study of Alogliptin in Patients With Type 2 Diabetes and Acute Coronary Syndrome

> **NCT00968708** · PHASE3 · COMPLETED · sponsor: **Takeda** · enrollment: 5380 (actual)

## Conditions studied

- Diabetes Mellitus, Type 2
- Acute Coronary Syndrome

## Interventions

- **DRUG:** Alogliptin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00968708
- **Lead sponsor:** Takeda
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-09
- **Primary completion:** 2013-04
- **Final completion:** 2013-06
- **Target enrollment:** 5380 (ACTUAL)
- **Last updated:** 2014-05-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00968708

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00968708, "Cardiovascular Outcomes Study of Alogliptin in Patients With Type 2 Diabetes and Acute Coronary Syndrome". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00968708. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*